Iterative crRNA design and a PAM-free strategy enabled an ultra-specific RPA-CRISPR/Cas12a detection platform

Xujian Mao1, Jian Xu2, Jingyi Jiang2

  • 1Pathogen Inspection Center, Changzhou Center for Disease Control and Prevention, Changzhou, Jiangsu, China. m5575383@163.com.

Communications Biology
|November 6, 2024
PubMed
Abstract